QuiVad

Home / Netherlands / Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 3.89% on March 1, 2024. The shaded band is the year shown above.

June 22, 2023 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

92 disclosures on record for this share.
DateFund% of capitalEnd of publication
February 14, 2025Citadel Securities (Europe) Limited0.49%still open
January 29, 2025Citadel Securities (Europe) Limited0.57%still open
January 24, 2025Citadel Securities (Europe) Limited0.62%still open
January 23, 2025Citadel Securities (Europe) Limited0.71%still open
January 22, 2025Citadel Securities (Europe) Limited0.67%still open
January 14, 2025Citadel Securities (Europe) Limited0.79%still open
January 13, 2025Citadel Securities (Europe) Limited0.60%still open
January 10, 2025Citadel Securities (Europe) Limited0.57%still open
January 2, 2025Citadel Securities (Europe) Limited0.47%still open
December 30, 2024Citadel Securities (Europe) Limited0.58%still open
December 27, 2024Citadel Securities (Europe) Limited0.61%still open
December 9, 2024Citadel Securities (Europe) Limited0.79%still open
December 6, 2024Citadel Securities (Europe) Limited0.62%still open
December 2, 2024Citadel Securities (Europe) Limited0.54%still open
September 24, 2024Citadel Securities (Europe) Limited0.42%still open
September 20, 2024Citadel Securities (Europe) Limited0.50%still open
September 19, 2024Citadel Securities (Europe) Limited0.49%still open
September 16, 2024Voleon Capital Management LP0.49%still open
September 12, 2024Voleon Capital Management LP0.57%still open
September 12, 2024Citadel Securities (Europe) Limited0.51%still open
September 11, 2024Voleon Capital Management LP0.77%still open
September 10, 2024Citadel Securities (Europe) Limited0.70%still open
September 5, 2024Voleon Capital Management LP0.87%still open
September 4, 2024Citadel Securities (Europe) Limited0.63%still open
September 3, 2024Citadel Securities (Europe) Limited0.51%still open
August 30, 2024Voleon Capital Management LP0.99%still open
August 16, 2024Voleon Capital Management LP1.09%still open
July 24, 2024Voleon Capital Management LP1.11%still open
July 22, 2024Citadel Securities (Europe) Limited0.20%still open
July 19, 2024Voleon Capital Management LP1.00%still open
July 18, 2024Citadel Securities (Europe) Limited0.60%still open
July 16, 2024Voleon Capital Management LP0.92%still open
July 16, 2024Citadel Securities (Europe) Limited0.77%still open
July 15, 2024Voleon Capital Management LP0.83%still open
July 12, 2024Voleon Capital Management LP0.74%still open
July 12, 2024Citadel Securities (Europe) Limited0.51%still open
July 2, 2024Voleon Capital Management LP0.61%still open
June 28, 2024Voleon Capital Management LP0.57%still open
June 21, 2024Millennium International Management LP0.45%still open
June 19, 2024Millennium International Management LP0.51%still open
June 17, 2024Millennium International Management LP0.61%still open
June 12, 2024Millennium International Management LP0.79%still open
June 10, 2024Millennium International Management LP0.84%still open
June 6, 2024Millennium International Management LP0.93%still open
May 29, 2024Millennium International Management LP1.09%still open
May 28, 2024GSA Capital Partners LLP0.47%still open
May 27, 2024GSA Capital Partners LLP0.50%still open
May 22, 2024Millennium International Management LP1.17%still open
May 15, 2024Millennium International Management LP1.29%still open
May 13, 2024Millennium International Management LP1.35%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Vivoryon Therapeutics N.V., source AFM, data as at February 14, 2025, https://www.quivad.com/action/vivoryon-therapeutics-n-v